16-1207298-C-T

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_021098.3(CACNA1H):​c.2931C>T​(p.Asn977Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000429 in 1,610,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000036 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.367

Publications

0 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 16-1207298-C-T is Benign according to our data. Variant chr16-1207298-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 529644.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.367 with no splicing effect.
BS2
High AC in GnomAd4 at 16 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.2931C>T p.Asn977Asn synonymous_variant Exon 14 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.2931C>T p.Asn977Asn synonymous_variant Exon 14 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.2931C>T p.Asn977Asn synonymous_variant Exon 14 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.2931C>T p.Asn977Asn synonymous_variant Exon 14 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.2931C>T p.Asn977Asn synonymous_variant Exon 14 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.2931C>T p.Asn977Asn synonymous_variant Exon 14 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.2931C>T p.Asn977Asn synonymous_variant Exon 14 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.2892C>T p.Asn964Asn synonymous_variant Exon 14 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.2931C>T p.Asn977Asn synonymous_variant Exon 14 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.2892C>T p.Asn964Asn synonymous_variant Exon 14 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.2931C>T p.Asn977Asn synonymous_variant Exon 14 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.2931C>T p.Asn977Asn synonymous_variant Exon 14 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.2931C>T p.Asn977Asn synonymous_variant Exon 14 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.2931C>T p.Asn977Asn synonymous_variant Exon 14 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.2931C>T p.Asn977Asn synonymous_variant Exon 14 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.2931C>T non_coding_transcript_exon_variant Exon 14 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.2931C>T non_coding_transcript_exon_variant Exon 14 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.2931C>T non_coding_transcript_exon_variant Exon 14 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*844C>T non_coding_transcript_exon_variant Exon 14 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*2378C>T non_coding_transcript_exon_variant Exon 13 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.2931C>T non_coding_transcript_exon_variant Exon 14 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.2931C>T non_coding_transcript_exon_variant Exon 14 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.2931C>T non_coding_transcript_exon_variant Exon 14 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.2931C>T non_coding_transcript_exon_variant Exon 14 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.2931C>T non_coding_transcript_exon_variant Exon 14 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.2931C>T non_coding_transcript_exon_variant Exon 14 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.2931C>T non_coding_transcript_exon_variant Exon 14 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.2931C>T non_coding_transcript_exon_variant Exon 14 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.2931C>T non_coding_transcript_exon_variant Exon 14 of 35 ENSP00000518777.1
CACNA1HENST00000640028.1 linkn.*844C>T 3_prime_UTR_variant Exon 14 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*2378C>T 3_prime_UTR_variant Exon 13 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.000105
AC:
16
AN:
152040
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000331
AC:
8
AN:
241824
AF XY:
0.0000228
show subpopulations
Gnomad AFR exome
AF:
0.000205
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000368
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000363
AC:
53
AN:
1458110
Hom.:
0
Cov.:
33
AF XY:
0.0000345
AC XY:
25
AN XY:
725094
show subpopulations
African (AFR)
AF:
0.000419
AC:
14
AN:
33416
American (AMR)
AF:
0.0000226
AC:
1
AN:
44288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26030
East Asian (EAS)
AF:
0.0000505
AC:
2
AN:
39616
South Asian (SAS)
AF:
0.0000233
AC:
2
AN:
85758
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52578
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.0000279
AC:
31
AN:
1110404
Other (OTH)
AF:
0.0000498
AC:
3
AN:
60260
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000105
AC:
16
AN:
152040
Hom.:
0
Cov.:
30
AF XY:
0.0000943
AC XY:
7
AN XY:
74252
show subpopulations
African (AFR)
AF:
0.000290
AC:
12
AN:
41410
American (AMR)
AF:
0.00
AC:
0
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
67988
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000773
Hom.:
0
Bravo
AF:
0.000102

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Dec 23, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
4.4
DANN
Benign
0.93
PhyloP100
-0.37

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs376470846; hg19: chr16-1257298; COSMIC: COSV100671249; COSMIC: COSV100671249; API